HCW Biologics Inc. (HCWB) stock
HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.75+0.01 (+1.90%)
Close on Nov 20, 2026Market cap $1.38MP/E –Yield –
HCW Biologics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
HCW Biologics's revenue for the twelve months ending Jun 30, 2026 was $6.66M, up 700.2% year over year. For fiscal 2025 it was $54.23K, down 97.9% from the year before. The highest annual figure on record is $6.72M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.23K | -97.9% |
| FY2024 | Dec 31, 2024 | $2.57M | -9.7% |
| FY2023 | Dec 31, 2023 | $2.84M | -57.7% |
| FY2022 | Dec 31, 2022 | $6.72M | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $4.10M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $121.73K | +1758.5% |
| Q1 FY2026 | Mar 31, 2026 | $6.50M | +128231.7% |
| Q4 FY2025 | Dec 31, 2025 | $27.01K | -93.2% |
| Q3 FY2025 | Sep 30, 2025 | $15.61K | -96.3% |
| Q2 FY2025 | Jun 30, 2025 | $6.55K | -98.9% |
| Q1 FY2025 | Mar 31, 2025 | $5.07K | -99.6% |
| Q4 FY2024 | Dec 31, 2024 | $394.80K | -70.2% |
| Q3 FY2024 | Sep 30, 2024 | $426.42K | -50.0% |
| Q2 FY2024 | Jun 30, 2024 | $618.85K | -0.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.13M | +2590.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.32M | -1.3% |
| Q3 FY2023 | Sep 30, 2023 | $853.10K | -52.8% |
| Q2 FY2023 | Jun 30, 2023 | $622.81K | +37.2% |
| Q1 FY2023 | Mar 31, 2023 | $41.88K | -98.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.34M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.81M | – |
| Q2 FY2022 | Jun 30, 2022 | $454.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $3.12M | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $4.10M | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
See a number that looks wrong?